Table 2.

Clinical applications for molecular immunohematology.

identify a fetus at risk for hemolytic disease of the newborn type a patient whose red cells are coated with immunoglobulin (DAT+) type a patient who has been recently transfused type patients and donors for antigens where antibodies are not available mass screen donors for antigen-negative blood types type donors for antibody identification panels resolve phenotype discrepancies (especially A, B D, and e) determine RHD zygosity identify null and novel alleles